ANPEP and hepatocellular carcinoma: In this study, we found that HCC patients with different CSC markers (CD133, CD90, CD13, CD24 or CD44) possessed distinct clinic-pathological features, suggesting that these cells with different cancer stem cell markers may be present in an identical HCC population.